Innovative MedTech Inc.
IMTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.63 | -0.20 | 0.03 |
| FCF Yield | 0.00% | -0.08% | -0.75% | 0.23% |
| EV / EBITDA | 161.81 | -494.17 | -13.17 | -12.60 |
| Quality | ||||
| ROIC | 173.50% | 3.48% | 70.24% | 64.85% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 96.88% |
| Cash Conversion Ratio | 0.88 | 0.20 | 0.09 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -37.14% | -18.60% | -2.71% | 9.10% |
| Free Cash Flow Growth | 16,662.68% | 81.23% | -590.84% | 127.49% |
| Safety | ||||
| Net Debt / EBITDA | 161.81 | -29.06 | -1.25 | -2.54 |
| Interest Coverage | -28.27 | -0.95 | -31.99 | -16.32 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -9,820.22 |